Rituximab in the treatment of Neuromyelitis optica: a multicentre Italian observational study von Annovazzi, Pietro, Capobianco, M., Moiola, L., Patti, F., Frau, J., Uccelli, A., Centonze, D., Perini, P., Tortorella, C., Prosperini, L., Lus, G., Fuiani, A., Falcini, M., Martinelli, V., Comi, G., Ghezzi, A.

Volltext

12-months prospective Pentraxin-3 and metabolomic evaluation in multiple sclerosis patients treated with glatiramer acetate von Signoriello, E., Iardino, P., Casertano, S., De Lucia, D., Pucciarelli, A., Puoti, G., Chiosi, E., Lus, G.

Volltext

Ocrelizumab in a case of refractory chronic inflammatory demyelinating polyneuropathy with anti‐rituximab antibodies von Casertano, S., Signoriello, E., Rossi, F., Di Pietro, A., Tuccillo, F., Bonavita, S., Lus, G.

Volltext

Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity von Patti, F, Messina, S, Solaro, C, Amato, M P, Bergamaschi, R, Bonavita, S, Bruno Bossio, R, Brescia Morra, V, Costantino, G F, Cavalla, P, Centonze, D, Comi, G, Cottone, S, Danni, M, Francia, A, Gajofatto, A, Gasperini, C, Ghezzi, A, Iudice, A, Lus, G, Maniscalco, G T, Marrosu, M G, Matta, M, Mirabella, M, Montanari, E, Pozzilli, C, Rovaris, M, Sessa, E, Spitaleri, D, Trojano, M, Valentino, P, Zappia, M

Volltext

Pregnancy effect on disease activity in women with multiple sclerosis treated with cladribine von Signoriello, E., Foschi, M., Lanzillo, R., Frau, J., Cocco, E., Borriello, G., Ianniello, A., Trotta, M., Landi, D., Maniscalco, G. T., Ruscica, F., Toscano, S., Patti, F., Zanghì, A., D’Amico, E., Fantozzi, R., Centonze, D., Lus, G., Bonavita, S.

Volltext

Adiponectin profile at baseline is correlated to progression and severity of multiple sclerosis von Signoriello, E., Lus, G., Polito, R., Casertano, S., Scudiero, O., Coletta, M., Monaco, M. L., Rossi, F., Nigro, E., Daniele, A.

Volltext

BMI influences CD20 kinetics in multiple sclerosis patients treated with ocrelizumab von Signoriello, E., Bonavita, S., Di Pietro, A., Abbadessa, G., Rossi, F., Miele, G., Casertano, S., Lus, G.

Volltext

Ocrelizumab Alters Cytotoxic Lymphocyte Function While Reducing EBV-Specific CD8 + T-Cell Proliferation in Patients With Multiple Sclerosis von Abbadessa, Gianmarco, Lepore, Maria Teresa, Bruzzaniti, Sara, Piemonte, Erica, Miele, Giuseppina, Signoriello, Elisabetta, Perna, Francesco, De Falco, Chiara, Lus, G, Matarese, Giuseppe, Bonavita, Simona, Galgani, Mario

Volltext

Lifestyle and Mediterranean diet adherence in a cohort of Southern Italian patients with Multiple Sclerosis von Esposito, S., Sparaco, M., Maniscalco, G.T., Signoriello, E., Lanzillo, R., Russo, C., Carmisciano, L., Cepparulo, S., Lavorgna, L., Gallo, A., Trojsi, F., Brescia Morra, V., Lus, G., Tedeschi, G., Saccà, F., Signori, A., Bonavita, S.

Volltext

Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration von Ferraro, D., Iaffaldano, P., Guerra, T., Inglese, M., Capobianco, M., Brescia Morra, V., Zaffaroni, M., Mirabella, M., Lus, G., Patti, F., Cavalla, P., Cellerino, M., Malucchi, S., Pisano, E., Vitetta, F., Paolicelli, D., Sola, P., Trojano, M.

Volltext

Real-life impact of early interferonβ therapy in relapsing multiple sclerosis von Trojano, M., Pellegrini, F., Paolicelli, D., Fuiani, A., Zimatore, G.B., Tortorella, C., Simone, I.L., Patti, F., Ghezzi, A., Zipoli, V., Rossi, P., Pozzilli, C., Salemi, G., Lugaresi, A., Bergamaschi, R., Millefiorini, E., Clerico, M., Lus, G., Vianello, M., Avolio, C., Cavalla, P., Lepore, V., Livrea, P., Comi, G., Amato, M.P.

Volltext

A snapshot on patient-reported outcome measures of people with multiple sclerosis on first-line therapies in a real world setting von Lanzillo, R., Sparaco, M., Lavorgna, L., Carmisciano, L., Signoriello, E., Signori, A., Costabile, T., Maniscalco, G. T., Saccà, F., Cepparulo, S., Russo, C. V., Bisecco, A., Frattaruolo, N., Strianese, A., Lus, G., Brescia Morra, V., Bonavita, S.

Volltext

Migraine as possible red flag of PFO presence in suspected demyelinating disease von Signoriello, E., Cirillo, M., Puoti, G., Signoriello, G., Negro, A., Koci, E., Melone, M.A.B., Rapacciuolo, A., Maresca, G., Lus, G.

Volltext

Lymphocytosis as a response biomarker of natalizumab therapeutic efficacy in multiple sclerosis von Signoriello, E, Lanzillo, R, Brescia Morra, V, Di Iorio, G, Fratta, M, Carotenuto, A, Lus, G

Volltext

Natalizumab in pediatric multiple sclerosis: results of a cohort of 55 cases von Ghezzi, A, Pozzilli, C, Grimaldi, LME, Moiola, L, Brescia-Morra, V, Lugaresi, A, Lus, G, Rinaldi, F, Rocca, MA, Trojano, M, Bianchi, A, Comi, G, Filippi, M

Volltext

Treatment withdrawal in relapsing−remitting multiple sclerosis: a retrospective cohort study von Lus, G., Signoriello, E., Maniscalco, G. T., Bonavita, S., Signoriello, S., Gallo, C.

Volltext

Is antibody titer useful to verify the immunization after VZV Vaccine in MS patients treated with Fingolimod? A case series von Signoriello, E., Bonavita, S., Sinisi, L., Russo, C.V., Maniscalco, G.T., Casertano, S., Saccà, F., Lanzillo, R., Morra, V. Brescia, Lus, G.

Volltext

Clinical predictors of Dimethyl Fumarate response in multiple sclerosis: a real life multicentre study von Lanzillo, R., Moccia, M., Palladino, R., Signoriello, E., Carotenuto, A., Maniscalco, G.T., Saccà, F., Bonavita, S., Russo, C.V., Iodice, R., Petruzzo, M., Sinisi, L., De Angelis, M., Lavorgna, L., De Rosa, A., Romano, F., Orlando, V., Ronga, B., Florio, C., Lus, G., Brescia Morra, V.

Volltext

Alemtuzumab significantly improves posterior fossa syndrome presented as a relapse of multiple sclerosis von Signoriello, E, D'Amico, A, Fratta, M, Ugga, L., Altobelli, C., Conchiglia, G., Barbarulo, A.M., Di Pietro, A., Anastasio, P., Rossi, F., Lus, G.

Volltext

Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice von Lanzillo, R., Bonavita, S., Quarantelli, M., Vacca, G., Lus, G., Amato, L., Carotenuto, A., Tedeschi, G., Orefice, G., Brescia Morra, V.

Volltext